In the present study we have found that after 20 weeks of diabetes, topical administration of GLP-1 resulted in a significant increase not only of these two important neuronal survival factors but of the entire PI3K/Akt/GSK3B/β-catenin pathway. This evidence concerns the gene GCG and diabetes mellitus.